Ruxolitinib
Incyte
['rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', 'derm', 'ruxolitinib']
ruxolitinib cream showed disease maintenance and symptom control with as-needed use over a 44-week period in adolescents and adults with atopic dermatitis. learn how the study was conducted from this #aad2023 poster session: 
Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products and drugs.